Detalles de la búsqueda
1.
Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls.
J Rheumatol
; 51(4): 415-422, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914221
2.
Efficacy of secukinumab on dactylitis in patients with active psoriatic arthritis from the FUTURE 5 study.
Clin Exp Rheumatol
; 41(3): 589-596, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35916290
3.
Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the Phase III FUTURE 5 study.
Clin Exp Rheumatol
; 40(5): 952-959, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34494957
4.
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials.
Rheumatol Int
; 42(2): 205-213, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34773130
5.
Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1.
BMC Musculoskelet Disord
; 22(1): 1037, 2021 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34903218
6.
Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study.
Eur J Haematol
; 95(3): 244-53, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25418187
7.
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications.
Rheumatol Ther
; 9(3): 935-955, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35305260
8.
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies.
Rheumatol Ther
; 8(1): 273-288, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33351179
9.
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies.
Arthritis Res Ther
; 21(1): 266, 2019 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31801620
10.
Clinical relevance of health-related quality of life outcomes with darifenacin.
BJU Int
; 102(2): 208-13, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18325056
11.
Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies.
RMD Open
; 4(2): e000749, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30564451
12.
Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.
Cancer Res
; 63(19): 6523-31, 2003 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14559846
13.
Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women.
Menopause
; 10(3): 241-9, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12792297
14.
Evaluation of irritation and sensitisation of two 50 microg/day oestrogen patches.
Maturitas
; 43(4): 257-63, 2002 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-12468134
15.
Dose proportionality study of four doses of an estradiol transdermal system, Estradot.
Maturitas
; 46(3): 173-85, 2003 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-14585520
Resultados
1 -
15
de 15
1
Próxima >
>>